Global Women's Health Academy
The Global Women's Health Academy (GWHA)series features late-breaking women's health education from leading clinical and public health experts across the world.
For more information about GWHA, visit www.globalwomenshealthacademy.org.
46-60 of 145
Matching TNBC Treatment Intensity to Patient Needs
Project Oncology®Matching TNBC Treatment Intensity to Patient Needs
Roberto Leon-Ferre, MD
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Project Oncology®Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Amy Comander, MD
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Project Oncology®Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS
Adam Brufsky, MD, PhD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Neil M. Iyengar, MD
Sarah H. Donahue, MPH, NP
MS in Women: How Life Stages Shape Treatment Decisions
NeuroFrontiersMS in Women: How Life Stages Shape Treatment Decisions
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerProtecting Heart Health in Metastatic Breast Cancer
Ryan Quigley
Gregory Vidal, MD, PhD
- advertisement
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerThe Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley
Gregory Vidal, MD, PhD
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast CancerAddressing Unmet Needs in First-Line mTNBC Care
Jennifer Caudle, DO, FACOFP
Alexis Ann LeVee, MD
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®Predicting Breast Cancer Metastasis with Proteomics
- advertisement
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast CancerHow ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP
Nick McAndrew, MD, MSCE